Xinjiang Baodi Mining (601121.SH) has received approval from the Shanghai Stock Exchange for the issuance of shares and payment of cash to purchase assets.
Bao Di Mining (601121.SH) announced that the company plans to purchase 82% of the equity of Xinjiang Congling Energy Co., Ltd. (referred to as "Congling Energy") from Kekzhou Congling Industrial Co., Ltd. through the issuance of shares and payment of cash, and plans to purchase 5% of the equity of Congling Energy from JAAN INVESTMENTS CO. LTD. through payment of cash. The company also plans to issue shares to no more than 35 specific investors including Xinjiang Geology Investment (Group) Co., Ltd. in compliance with the conditions set by the China Securities Regulatory Commission, and raise matching funds.
Xinjiang Baodi Mining (601121.SH) announced that the company intends to purchase 82% of the equity of Xinjiang Congling Energy Co., Ltd. (referred to as "Congling Energy") from Kekzhou Congling Industry Co., Ltd. through the issuance of shares and cash payment. The company also plans to purchase 5% of the equity of Congling Energy from JAAN INVESTMENTS CO. LTD. through cash payment, and to issue shares to a maximum of 35 specific investors, including Xinjiang Geology Mining Investment (Group) Co., Ltd., to raise additional funds. The Mergers and Acquisitions Committee of the Shanghai Stock Exchange (referred to as the "SSE M&A Committee") held its 19th meeting on December 5, 2025 to review the company's application for this transaction. According to the announcement of the results of the 19th meeting of the Mergers and Acquisitions Committee of the Shanghai Stock Exchange in 2025 released by the SSE M&A Committee, the result of the meeting is that this transaction meets the requirements for restructuring and disclosure of information.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






